Condition: Primary Dysmenorrhea · Chronic Pelvic Pain · Sponsor: Nantes University Hospital
The objective of the study is to evaluate the global impression of improvement at 3 months following intramyometrial botulinum toxin injections via hysteroscopy in women with severe primary dysmenorrhea who have failed first-line medical treatment, compared to intramyometrial placebo injections.
This description comes directly from the study's public registry record.
Claire CARDAILLAC · +33 2 53 48 23 50 · claire.cardaillac@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| Clinique axium / Centre resilience | Aix-en-Provence, France | Recruiting |
| CHU Angers | Angers, France | Recruiting |
| CHU Brest | Brest, France | Recruiting |
| CHU Lille | Lille, France | Recruiting |
| Hôpital de la Croix-Rousse | Lyon, France | Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| Clinique Brétéché | Nantes, France | Recruiting |
| CHU Rennes | Rennes, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06995287